Gabriela Paz-Bailey
Overview
Explore the profile of Gabriela Paz-Bailey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
200
Citations
3596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kiplagat S, Tavale N, Konrote A, Johansson A, Papu A, Perez-Padilla J, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Aug;
73(31):686-688.
PMID: 39116023
No abstract available.
12.
Madewell Z, Major C, Graff N, Adams C, Rodriguez D, Morales T, et al.
Influenza Other Respir Viruses
. 2024 Jul;
18(7):e13305.
PMID: 39053895
Background: The COVID-19 pandemic underscored the need for rapid and accurate diagnostic tools. In August 2020, the Abbott BinaxNOW COVID-19 Antigen Card test became available as a timely and affordable...
13.
Wegman A, Kalimuddin S, Marques E, Adams L, Rothman A, Gromowski G, et al.
Vaccine
. 2024 Jun;
42(23):126071.
PMID: 38890105
The first dengue "endgame" summit was held in Syracuse, NY over August 9 and 10, 2023. Organized and hosted by the Institute for Global Health and Translational Sciences at SUNY...
14.
Madewell Z, Hernandez-Romieu A, Wong J, Zambrano L, Volkman H, Perez-Padilla J, et al.
MMWR Surveill Summ
. 2024 May;
73(3):1-29.
PMID: 38805389
Problem/condition: Dengue is the most prevalent mosquitoborne viral illness worldwide and is endemic in Puerto Rico. Dengue's clinical spectrum can range from mild, undifferentiated febrile illness to hemorrhagic manifestations, shock,...
15.
Medina F, Vila F, Adams L, Cardona J, Carrion J, Lamirande E, et al.
medRxiv
. 2024 May;
PMID: 38712100
The Advisory Committee on Immunization Practices (ACIP) recommended that dengue pre-vaccination screening tests for Dengvaxia administration have at least 98% specificity and 75% sensitivity. This study evaluates the performance of...
16.
Taylor-Salmon E, Hill V, Paul L, Koch R, Breban M, Chaguza C, et al.
Nat Commun
. 2024 Apr;
15(1):3508.
PMID: 38664380
Dengue is the most prevalent mosquito-borne viral disease in humans, and cases are continuing to rise globally. In particular, islands in the Caribbean have experienced more frequent outbreaks, and all...
17.
Major C, Rodriguez D, Sanchez-Gonzalez L, Rodriguez-Estrada V, Morales-Ortiz T, Torres C, et al.
JMIR Res Protoc
. 2024 Apr;
13:e53837.
PMID: 38640475
Background: A better understanding of SARS-CoV-2 infection risk among Hispanic and Latino populations and in low-resource settings in the United States is needed to inform control efforts and strategies to...
18.
Rosado-Santiago C, Perez-Guerra C, Velez-Agosto N, Colon-Burgos C, Marrero-Santos K, Partridge S, et al.
Hum Vaccin Immunother
. 2024 Apr;
20(1):2323264.
PMID: 38599678
Dengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9-16 y with laboratory-confirmed previous dengue infection and living in areas where...
19.
Perez-Guerra C, Rosado-Santiago C, Ramos S, Marrero-Santos K, Gonzalez-Zeno G, Partridge S, et al.
PLOS Glob Public Health
. 2024 Mar;
4(3):e0002744.
PMID: 38446807
Aedes aegypti control has been fraught with challenges in Puerto Rico. The government has implemented commonly used vector control methods, but arboviral epidemics still occur. It is necessary to explore...
20.
Kada S, Paz-Bailey G, Adams L, Johansson M
PLoS Negl Trop Dis
. 2024 Mar;
18(3):e0011143.
PMID: 38427702
Dengue viruses (DENV) are endemic in the US territories of Puerto Rico, American Samoa, and the US Virgin Islands, with focal outbreaks also reported in the states of Florida and...